Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01855828
Title Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lajos Pusztai
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale University Smilow Cancer Hospital New Haven Connecticut 06520 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field